Literature DB >> 30681007

Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France.

Christos Chouaid1, Nicola Germain2, Gérard De Pouvourville3, Samuel Aballéa2, Daria Korchagina2, Michael Baldwin4, Katell Le Lay5, Laura Luciani5, Mondher Toumi6, Philippe Devillier7.   

Abstract

OBJECTIVES: Understanding inhaler preferences may contribute to improving adherence in COPD patients and improving long-term outcomes. This study aims to identify and quantify preferences for convenience-related inhaler attributes in French moderate-to-severe COPD patients, with discrete choice experiment (DCE) methodology.
METHODS: Attributes were defined from a literature search, clinician and patient interviews: shape, dose insertion, dose preparation, dose release, dose confirmation, dose counter and reusability. An online DCE was conducted in respondents with self-reported COPD stage 2-4 recruited through a panel. The study questionnaire included twelve choice scenarios per respondent and questions on patient characteristics, treatment and disease severity. Statistical analyses used a mixed logit regression model with random effects. Utility scores were estimated for four types of inhalers: Inhaler A - soft mist inhaler; Inhaler B - reusable soft mist inhaler; Inhaler C - multi-dose dry powder inhaler; and Inhaler D - single dose dry powder inhaler.
RESULTS: The study was completed by 153 patients (50 females); respondents were 50.4 years old on average; 13 different inhaler devices were reported. The most preferred inhaler is L-shaped, has dose preparation with capsule insertion and a dose counter, and is reusable. Inhaler profiles A and B had the highest utilities (mean of 1.2533 and 0.9578 respectively) compared to inhaler C (0.6315) and D (0.2200).
CONCLUSIONS: This study showed statistically significant results that the strongest drivers of preference in French users of inhalation devices for COPD are shape, dose counter and reusability. Convenience-related characteristics are important to patients and should be taken into account by clinicians prescribing these devices.

Entities:  

Keywords:  COPD; Chronic obstructive pulmonary disease; convenience; discrete choice experiment; inhaler characteristics; inhaler device; patient preference

Mesh:

Year:  2019        PMID: 30681007     DOI: 10.1080/03007995.2019.1574507

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  11 in total

1.  People living with moderate-to-severe COPD prefer improvement of daily symptoms over the improvement of exacerbations: a multicountry patient preference study.

Authors:  Nigel S Cook; Gerard J Criner; Pierre-Régis Burgel; Katie Mycock; Tom Gardner; Phil Mellor; Pam Hallworth; Kate Sully; Sophi Tatlock; Beyza Klein; Byron Jones; Olivier Le Rouzic; Kip Adams; Kirsten Phillips; Mike McKevitt; Kazuko Toyama; Florian S Gutzwiller
Journal:  ERJ Open Res       Date:  2022-06-13

2.  Evaluation of Suboptimal Peak Inspiratory Flow in Patients with Stable COPD.

Authors:  Cristina Represas-Represas; Luz Aballe-Santos; Alberto Fernández-García; Ana Priegue-Carrera; José-Luis López-Campos; Almudena González-Montaos; Maribel Botana-Rial; Alberto Fernández-Villar
Journal:  J Clin Med       Date:  2020-12-05       Impact factor: 4.241

3.  Preferences of patients with asthma or COPD for treatments in pulmonary rehabilitation.

Authors:  Kathrin Damm; Heidrun Lingner; Katharina Schmidt; Ines Aumann-Suslin; Heike Buhr-Schinner; Jochen van der Meyden; Konrad Schultz
Journal:  Health Econ Rev       Date:  2021-04-17

4.  Assessing Patient Preferences in Rare Diseases: Direct Preference Elicitation in the Rare Chronic Kidney Disease, Immunoglobulin A Nephropathy.

Authors:  Kevin Marsh; Kerrie-Anne Ho; Rachel Lo; Nancy Zaour; Aneesh Thomas George; Nigel S Cook
Journal:  Patient       Date:  2021-05-19       Impact factor: 3.883

5.  Treatment Preferences of Patients with Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups in the United Kingdom, United States, and Germany.

Authors:  Melanie Schroeder; Katie Hall; Lina Eliasson; Sophia Bracey; Necdet B Gunsoy; Jake Macey; Paul W Jones; Afisi S Ismaila
Journal:  Chronic Obstr Pulm Dis       Date:  2021-01

6.  Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences.

Authors:  Shaonan Liu; Jiaqi Lai; Lei Wu; Xinfeng Guo
Journal:  Patient Prefer Adherence       Date:  2021-07-08       Impact factor: 2.711

7.  Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis.

Authors:  Maryam Navaie; Carole Dembek; Soojin Cho-Reyes; Karen Yeh; Bartolome R Celli
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

Review 8.  Status of and strategies for improving adherence to COPD treatment.

Authors:  José Luis López-Campos; Esther Quintana Gallego; Laura Carrasco Hernández
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-07-10

9.  A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT® Re-usable in the Nordics and Benelux.

Authors:  Gustaf Ortsäter; Fredrik Borgström; Stéphane Soulard; Carolin Miltenburger
Journal:  Adv Ther       Date:  2019-10-17       Impact factor: 3.845

10.  A Systematic and Critical Review of Discrete Choice Experiments in Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Hannah Collacott; Dian Zhang; Sebastian Heidenreich; Tommi Tervonen
Journal:  Patient       Date:  2021-07-12       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.